Featured Research

from universities, journals, and other organizations

NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions

Date:
August 12, 1997
Source:
UT Southwestern Medical Center
Summary:
Imagine mixing tiny amounts of proteins and other biological molecules in a thousandth of a second and then studying the reactions that take place in a tenth of a second.

DALLAS ― August 12, 1997 ― Imagine mixing tiny amounts of proteins and other biological molecules in a thousandth of a second and then studying the reactions that take place in a tenth of a second. A National Institutes of Health (NIH) grant has enabled UT Southwestern Medical Center at Dallas researchers to purchase equipment that makes possible sensitive measurements of the fastest biological processes.

The NIH awarded a $180,000 Shared Equipment Grant to seven UT Southwestern investigators to obtain state-of-the-art rapid mixing and optical monitoring instruments, available to only a few medical centers in the country. The competitive funding is given to scientists who show they can make full use of a sophisticated and expensive laboratory instrument.

"No one of us could justify spending that kind of money to purchase this equipment for any individual project, but a shared facility of this kind is a wonderful asset to our research," said Dr. Elliott Ross, professor of pharmacology and holder of the Greer Garson and E.E. Fogelson Distinguished Chair in Medical Research.

"These instruments let us look at the rates and progress of fast biochemical reactions. By fast, I mean from less than one millisecond to five seconds. This means that we can study the details of how these reactions happen and the chemical nature of their intermediates. For instance, when a light flashes, how fast does the amplifying biochemistry in your retina record that information? How does it work? With this machine, you can actually determine the rates of those reactions," he said.

The instrument is based on four computer-controlled syringes. The syringes independently ― and very quickly ― mix reagents by injecting them into a series of three tiny mixing chambers, each only 15 microliters in volume (five ten-thousandths of an ounce). After mixing, the instrument can do two types of analyses. In the first, called stopped-flow, the reaction mixture is driven into a small quartz chamber, where several different optical techniques can be used to follow the course of the reaction. In the second, called quench-flow, the reaction is stopped at precise times, and the mixture is collected for chemical analysis.

The versatility of the new instrument is crucial for its shared use. Stopped-flow absorbance measurements -- looking at colored reaction intermediates -- can be used to follow complex enzyme reactions. Stopped-flow circular dichroism, which monitors molecular shape, can follow the rapid folding of a protein into its active conformation. Stopped-flow fluorescence can measure the binding of proteins to each other, changes in their structures and many other parameters. Quench-flow is used when no optical probe is available. To obtain such versatility, the UT Southwestern researchers worked with the manufacturer, BioLogic S.A., of Grenoble, France, to combine and adapt the necessary components. Specifications on the final order were six pages long and included several custom-designed items.

One UT Southwestern scientist sharing this machine, Dr. Margaret Phillips, assistant professor of pharmacology, will use it to study reactions catalyzed by several enzymes in trypanosomes, the parasites that cause sleeping sickness and Chagas' disease. Dr. Julian Peterson, professor of biochemistry, will use stop-flow spectroscopy to study the functions of P450s, a large class of enzymes that can degrade drugs, synthesize hormones and inactivate toxins. Dr. Philip Thomas, assistant professor of physiology, and Dr. Elizabeth Goldsmith, associate professor of biochemistry, will use circular dichroism to study how proteins fold and how regulators of enzyme action change the structure of their enzyme targets.

Ross and his group study signaling proteins that convey information from drug and neurotransmitter receptors to intracellular regulatory proteins. They will use quench-flow measurements to determine how stimulatory and inhibitory signals combine on the millisecond time scale to organize incoming signaling pathways.

"We are trying to measure these individual processes and how they are regulated," Ross said. "Determining the real turn-on and turn-off rates and what regulates the speed of these reactions has not really been done before.

"Where and when a response turns on and turns off is essential information. For instance, when you read, you are taking in a lot of light, but it's the cut-off between black and white that is important; when you hear a voice, the changes convey the information."

Ross said that stop-flow instruments have existed for 30 years, but previous ones were inefficient. They were too slow ― the fastest could not measure reactions faster than about 20 milliseconds ― and they required too much reagent, often 1,000 times more than is needed now.

"Five years ago, I wouldn't have dreamed of doing this kind of experiment because the equipment wasn't up to it," he said. "We couldn't possibly make enough enzyme or get enough sensitivity."

Other UT Southwestern researchers sharing in the grant are Dr. Joseph Albanesi, associate professor of pharmacology; Dr. James Stull, chairman of physiology and holder of the Fouad A. Bashour Chair in Physiology; and Dr. Clive Slaughter, associate professor of biochemistry and Howard Hughes Medical Institute investigator.

Ross said the researchers on the grant will have priority use of the equipment, but other NIH-funded UT Southwestern scientists will be able to use the instruments as well.

###

This news release is available on our World Wide Web home page at http://www.swmed.edu/news/newspubs.htm/


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions." ScienceDaily. ScienceDaily, 12 August 1997. <www.sciencedaily.com/releases/1997/08/970812002257.htm>.
UT Southwestern Medical Center. (1997, August 12). NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/1997/08/970812002257.htm
UT Southwestern Medical Center. "NIH Grant Allows UT Southwestern Researchers To Study Fast Biochemical Reactions." ScienceDaily. www.sciencedaily.com/releases/1997/08/970812002257.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins